PCB-77 disturbs iron homeostasis through regulating hepcidin gene expression

Gene

Volumn 532, Issue 1, 2013, Pages 146-151

  Wang, Lei ^a   Zhang, Shuping ^a   Lin, Ronghai ^b   Li, Long ^a   Zhang, Daoqiang ^b   Li, Xinghong ^a   Liu, Sijin ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocytes; Hepcidin; Iron homeostasis; PCB 77

Indexed keywords

3,3',4,4' TETRACHLOROBIPHENYL; HEPCIDIN; IRON; POLYCHLORINATED BIPHENYL;

ANIMAL EXPERIMENT; ARTICLE; BIOLOGICAL ACTIVITY; CELL MEMBRANE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IRON BLOOD LEVEL; IRON HOMEOSTASIS; IRON METABOLISM; IRON OVERLOAD; LIPOPHILICITY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3,3′,4,4′-TETRACHLOROBIPHENYL; 3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE; BMP; BONE MORPHOGENETIC PROTEIN; DIMETHYLSULFOXIDE; DMSO; ERE; ESTROGEN RESPONSE ELEMENTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GC-MS; HEPATOCYTES; HEPCIDIN; IL-6; INTERLEUKIN- 6; IRON HOMEOSTASIS; LACTATE DEHYDROGENASE; LDH; MTT; PCB-77; PCBS; POLYCHLORINATED BIPHENYLS; QRT-PCR; QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HEPCIDINS; HOMEOSTASIS; HUMANS; IRON; LIVER; MICE; MICE, INBRED BALB C; POLYCHLORINATED BIPHENYLS; SPLEEN;

MUS;

EID: 84885371417     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.023     Document Type: Article

References (54)

1. Andriopoulos B., et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 2009, 41:482-487.
2. Anker S.D., et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med. 2009, 361:2436-2448.
3. Aronson K.J., et al. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 2000, 9:55-63.
4. Banzet S., Sanchez H., Chapot R., Bigard X., Vaulont S., Koulmann N. Interleukin-6 contributes to hepcidin mRNA increase in response to exercise. Cytokine 2012, 58:158-161.
5. Bekri S., et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006, 131:788-796.
6. Benarroch E.E. Brain iron homeostasis and neurodegenerative disease. Neurology 2009, 72:1436-1440.
7. Birnbaum L.S. Endocrine effects of prenatal exposure to PCBs, dioxins, and other xenobiotics: implications for policy and future research. Environ. Heal. Perspect. 1994, 102:676.
8. Burgin D.E., Diliberto J.J., Derr-Yellin E.C., Kannan N., Kodavanti P., Birnbaum L.S. Differential effects of two lots of aroclor 1254 on enzyme induction, thyroid hormones, and oxidative stress. Environ. Heal. Perspect. 2001, 109:1163.
9. Bystrom L.M., Guzman M., Rivella S. Iron and ROS: friends or foes of cancer?. Antioxid. Redox Signal. 2012, 121202124904000.
10. COLE D.R., PLAPP F.W. Inhibition of growth and photosynthesis in Chlorella pyrenoidosa by a polychlorinated biphenyl and several insecticides. Environ. Entomol. 1974, 3:217-220.
11. Drakesmith H., Prentice A.M. Hepcidin and the iron-infection axis. Science 2012, 338:768-772.
12. Duce J.A., et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 2010, 142:857-867.
13. Elizabeta Nemeth M.S.T., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
14. Evstatiev R., Gasche C. Iron sensing and signalling. Gut 2012, 61:933-952.
15. Fei S., Fengqun Z., Chunji L. Clinical meaning of serum ferritin, iron in chronic hepatitic B [J]. J. Xi'an Jiaotong Univ. (Med. Sci.) 2006, 3:024.
16. Ferrucci L., et al. Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br. J. Cancer 2009, 101:178-184.
17. Ganeshaguru K., Hoffbrand A.V., Grady R.W., Cerami A. Effect of various iron chelating agents on DNA synthesis in human cells. Biochem. Pharmacol. 1980, 29:1275-1279.
18. Ganz T. The role of hepcidin in iron homeostasis. Iron Deficiency and Overload 2010, 51-64. Springer.
19. Ganz T., Nemeth E. The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. ASH Education Program Book 2011 2011, 538-542.
20. Ghosh K. Non haematological effects of iron deficiency - a perspective. Indian J. Med. Sci. 2006, 60:30-37.
21. Halpern Z., Rahmani R., Levo Y. Severe hemochromatosis: the predominant clinical manifestation of congenital dyserythropoietic anemia type 2. Acta Haematol. 2009, 74:178-180.
22. Hawkins D.H., Abrahamse H. The role of laser fluence in cell viability, proliferation, and membrane integrity of wounded human skin fibroblasts following helium-neon laser irradiation. Lasers Surg. Med. 2006, 38:74-83.
23. Hou Y., et al. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 2012, 511:398-403.
24. Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 2003, 278:27144-27148.
25. Kallianpur A.R., et al. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res. Treat. 2008, 107:123-132.
26. Knutson M.D., Walter P.B., Ames B.N., Viteri F.E. Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. J. Nutr. 2000, 130:621-628.
27. Kodavanti P., Tilson H. Structure-activity relationships of potentially neurotoxic PCB congeners in the rat. Neurotoxicology 1996, 18:425-441.
28. Kodavanti P.R.S., et al. Congener-specific distribution of polychlorinated biphenyls in brain regions, blood, liver, and fat of adult rats following repeated exposure to Aroclor 1254. Toxicol. Appl. Pharmacol. 1998, 153:199-210.
29. Kuch B., Kern F., Metzger J.W., von der Trenck K.T. Effect-related monitoring: estrogen-like substances in groundwater. Environ. Sci. Pollut. Res. 2010, 17:250-260.
30. Liu S., et al. The function of heme-regulated eIF2alpha kinase in murine iron homeostasis and macrophage maturation. J. Clin. Invest. 2007, 117:3296-3305.
31. Loch-Caruso R. Uterine muscle as a potential target of polychlorinated biphenyls during pregnancy. Int. J. Hyg. Environ. Health 2002, 205:121-130.
32. Lucena R.A., Allam M.F., Costabeber I.H., Villarejo M.L., Navajas R.F. Breast cancer risk factors: PCB congeners. Eur. J. Cancer Prev. 2001, 10:117-119.
33. Młynarczuk J., Kotwica J. Influence of polychlorinated biphenyls on LH-stimulated secretion of progestereone and oxytocin from bovine luteal cells. Pol. J. Vet. Sci. 2006, 9:101.
34. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr. 2006, 26:323-342.
35. Nemeth E., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 2004, 113:1271-1276.
36. Nicolas G., et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Sci. Signal. 2001, 98:8780.
37. Pak M., Lopez M.A., Gabayan V., Ganz T., Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006, 108:3730-3735.
38. Pennell D.J., et al. Efficacy of deferasirox in reducing and preventing cardiac iron overload in β-thalassemia. Blood 2010, 115:2364-2371.
39. Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications. J. Hepatol. 2011, 54:173.
40. Portigal C.L., Cowell S.P., Fedoruk M.N., Butler C.M., Rennie P.S., Nelson C.C. Polychlorinated biphenyls interfere with androgen-induced transcriptional activation and hormone binding. Toxicol. Appl. Pharmacol. 2002, 179:185-194.
41. Richardson D., Kalinowski D., Lau S., Jansson P., Lovejoy D. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim. Biophys. Acta Gen. Subj. 2009, 1790:702-717.
42. Richthoff J., et al. Serum levels of 2, 2', 4, 4', 5, 5'-hexachlorobiphenyl (CB-153) in relation to markers of reproductive function in young males from the general Swedish population. Environ. Heal. Perspect. 2003, 111:409.
43. Safe S.H. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit. Rev. Toxicol. 1994, 24:87-149.
44. Schantz S.L., Widholm J.J., Rice D.C. Effects of PCB exposure on neuropsychological function in children. Environ. Health Perspect. 2003, 111:357-576.
45. Serrano J., Puupponen-Pimiä R., Dauer A., Aura A.M., Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol. Nutr. Food Res. 2009, 53:S310-S329.
46. Smialowicz R.J., Andrews J.E., Riddle M.M., Rogers R.R., Luebke R.W., Copeland C.B. Evaluation of the immunotoxicity of low level PCB exposure in the rat. Toxicology 1989, 56:197-211.
47. Snedeker S.M. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ. Heal. Perspect. 2001, 109:35.
48. Torti S.V., Torti F.M. Ironing out cancer. Cancer Res. 2011, 71:1511-1514.
49. Tryphonas H. Immunotoxicity of PCBs (aroclors) in relation to Great Lakes. Environ. Heal. Perspect. 1995, 103:35.
50. Wolff M.S., Zeleniuch-Jacquotte A., Dubin N., Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev. 2000, 9:271-277.
51. Woolcott C.G., et al. Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 2001, 12:395-404.
52. Yang Q., Jian J., Katz S., Abramson S.B., Huang X. 17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012, 153:3170-3178.
53. Yoshimura H., Yoshihara S.i., Ozawa N., Miki M. Possible correlation between induction modes of hepatic enzymes by PCBs and their toxicity in rats. Ann. N. Y. Acad. Sci. 1979, 320:179-192.
54. Zheng T., et al. Breast cancer risk associated with congeners of polychlorinated biphenyls. Am. J. Epidemiol. 2000, 152:50-58.